Survival data from patients with advanced or metastatic renal cell carcinoma in routine practice differs significantly from clinical trial data – Analyses from the German clinical RCC Registry.

Goebell, P., Müller, L., Staehler, M., Nusch, A., Münz, M., Koska, M., Jänicke, M., Marschner, N., 2015.

Eur Urol Suppl 14 (2)(abstract 6), e6. doi:10.1016/S1569-9056(15)60009-4

Studie: TNK; Indikation: Nierenzellkarzinom; Jahr: 2015; Veranstaltung: EAU; Journal: European Urology

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0